Torres-Adorno, Angie M.
Vitrac, Heidi
Qi, Yuan
Tan, Lin
Levental, Kandice R.
Fan, Yang-Yi
Yang, Peiying
Chapkin, Robert S.
Eckhardt, Bedrich L.
Ueno, Naoto T.
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01CA123318)
Article History
Received: 2 May 2018
Revised: 26 September 2018
Accepted: 17 October 2018
First Online: 20 November 2018
Compliance with ethical standards
:
: The authors declare that they have no conflict of interest.
: This work was supported by the Morgan Welch Inflammatory Breast Cancer Research Program, the State of Texas Rare and Aggressive Breast Cancer Research Program, the National Institutes of Health/National Cancer Institute through grants R01CA123318 and P30CA016672 (used the Characterized Cell Line Core, the Flow Cytometry and Cellular Imaging Facility, and the Bioinformatics Shared Resource at MD Anderson Cancer Center), the Cancer Prevention and Research Institute of Texas through grant RP110532-P3 (used MD Anderson’s siRNA Screening Service), and the John Dunn Research Foundation Endowment awarded to William Dowhan.